[Quantitative determination of the fibrinolytic tissue activator in normal and pathological skin].
D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000473:pathology; D002908:Chronic Disease; D003864:Depression, Chemical; D004485:Eczema / Q000473:pathology; D005342:Fibrinolysis / Q000502:physiology*; D005343:Fibrinolytic Agents / Q000032:analysis*; D005350:Fibroma / Q000473:pathology; D006651:Histocytochemistry; D006801:Humans; D007057:Ichthyosis / Q000473:pathology; D011565:Psoriasis / Q000473:pathology; D012867:Skin / Q000032:analysis*; D012871:Skin Diseases / Q000188:drug therapy / Q000473:pathology*; D012878:Skin Neoplasms / Q000473:pathology
D000933:Antifibrinolytic Agents; D005343:Fibrinolytic Agents
Quantitative Bestimmung des Gewebsaktivators der Fibrinolyse in gesunder und kranker Haut.